Phenotypic Spectrum of Transthyretin Cardiac Amyloidosis in a Family: Impact of Mutation Zygosity and Sex.
作者信息
Tushak Zackary J, Doshi Amar, Trankle Cory R, Rao Kris, Cei Laura, Shah Keyur B
机构信息
Division of Cardiology, Virginia Commonwealth University Health, Pauley Heart Center, Richmond, Virginia, USA.
出版信息
JACC CardioOncol. 2021 Oct 19;3(4):602-605. doi: 10.1016/j.jaccao.2021.07.006. eCollection 2021 Oct.
Abstract
摘要
相似文献
1
Phenotypic Spectrum of Transthyretin Cardiac Amyloidosis in a Family: Impact of Mutation Zygosity and Sex.一个家族中甲状腺转运蛋白性心脏淀粉样变性的表型谱：突变纯合性和性别的影响
JACC CardioOncol. 2021 Oct 19;3(4):602-605. doi: 10.1016/j.jaccao.2021.07.006. eCollection 2021 Oct.
2
The use of PYP scan for evaluation of ATTR cardiac amyloidosis at a tertiary medical centre.在一家三级医疗中心使用PYP扫描评估转甲状腺素蛋白淀粉样变心肌病
Br J Cardiol. 2022 May 31;29(2):19. doi: 10.5837/bjc.2022.019. eCollection 2022.
3
Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy.转甲状腺素蛋白淀粉样变心肌病患者预后评估的最佳实践
JACC CardioOncol. 2019 Dec 17;1(2):273-279. doi: 10.1016/j.jaccao.2019.11.006. eCollection 2019 Dec.
4
Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study?野生型心脏淀粉样变：是否到了开核素焦磷酸盐 SPECT 成像研究的时间？
Int J Cardiovasc Imaging. 2023 Jan;39(1):201-208. doi: 10.1007/s10554-022-02692-y. Epub 2022 Jul 15.
5
A case report of an uncommon presentation of technetium pyrophosphate scintigraphy in transthyretin cardiac amyloidosis: A potential diagnostic pitfall, pseudo-positive or pseudo-negative?转甲状腺素蛋白心脏淀粉样变性中焦磷酸锝闪烁显像罕见表现的病例报告：潜在的诊断陷阱、假阳性还是假阴性？
J Cardiol Cases. 2019 Oct 8;21(2):50-53. doi: 10.1016/j.jccase.2019.09.013. eCollection 2020 Feb.
6
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.多中心研究 99mTc 焦磷酸盐平面心肌显像术：预测ATTR 心脏淀粉样变性患者的生存率。
JAMA Cardiol. 2016 Nov 1;1(8):880-889. doi: 10.1001/jamacardio.2016.2839.
7
Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy.锝-99m焦磷酸盐单光子发射计算机断层扫描/计算机断层扫描在监测遗传性转甲状腺素蛋白淀粉样心肌病患者RNA干扰疗法治疗变化中的应用。
J Formos Med Assoc. 2025 Apr;124(4):333-339. doi: 10.1016/j.jfma.2024.10.005. Epub 2024 Oct 10.
8
9
Utility of Tc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice.锝-焦磷酸盐闪烁扫描术在实际临床实践中诊断转甲状腺素蛋白型心脏淀粉样变的效用
Circ Rep. 2019 Jun 14;1(7):277-285. doi: 10.1253/circrep.CR-19-0015.
10
Use of Technetium-99m-Pyrophosphate Single-Photon Emission Computed Tomography/Computed Tomography in Monitoring Therapeutic Changes of Eplontersen in Patients With Hereditary Transthyretin Amyloid Cardiomyopathy.应用锝-99m-焦磷酸盐单光子发射计算机断层扫描/计算机断层扫描监测遗传性转甲状腺素蛋白淀粉样心肌病患者依罗替尼治疗的变化。
J Am Heart Assoc. 2024 Jan 16;13(2):e030512. doi: 10.1161/JAHA.123.030512. Epub 2024 Jan 12.
引用本文的文献
1
Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis.他法米地斯可改善A97S转甲状腺素蛋白心脏淀粉样变性患者的心肌纵向应变。
Ther Adv Chronic Dis. 2024 Jan 11;15:20406223231222828. doi: 10.1177/20406223231222828. eCollection 2024.
本文引用的文献
1
Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review.转甲状腺素蛋白淀粉样变心肌病（ATTR-CM）患者延迟诊断和误诊的影响：一项针对性文献综述
Cardiol Ther. 2021 Jun;10(1):141-159. doi: 10.1007/s40119-021-00219-5. Epub 2021 Apr 20.
2
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.避免误诊：全科医生对转甲状腺素蛋白淀粉样变性的疑诊和诊断的专家共识建议。
BMC Fam Pract. 2020 Sep 23;21(1):198. doi: 10.1186/s12875-020-01252-4.
3
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.双氯芬酸对转甲状腺素蛋白（ATTR）心脏淀粉样变性患者心脏功能的稳定作用
J Card Fail. 2020 Sep;26(9):753-759. doi: 10.1016/j.cardfail.2019.11.024. Epub 2019 Dec 2.
4
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.特发性甲状腺素运载蛋白淀粉样变心肌病患者的塔法米迪治疗。
N Engl J Med. 2018 Sep 13;379(11):1007-1016. doi: 10.1056/NEJMoa1805689. Epub 2018 Aug 27.
5
Transthyretin Cardiac Amyloidosis in Black Americans.美国黑人中的转甲状腺素蛋白心脏淀粉样变
Circ Heart Fail. 2016 Jun;9(6):e002558. doi: 10.1161/CIRCHEARTFAILURE.115.002558.
6
Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life.转甲状腺素蛋白 V122I 突变纯合子与非洲裔美国人在 70 多岁时心脏淀粉样变性的发病更早相关。
J Mol Diagn. 2014 Jan;16(1):68-74. doi: 10.1016/j.jmoldx.2013.08.001. Epub 2013 Oct 30.
7
Transthyretin (TTR) cardiac amyloidosis.转甲状腺素蛋白（TTR）心脏淀粉样变性
Circulation. 2012 Sep 4;126(10):1286-300. doi: 10.1161/CIRCULATIONAHA.111.078915.
8
A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population.非裔美国人人群中转甲状腺素蛋白Ile122等位基因频率的前瞻性评估。
Amyloid. 2005 Jun;12(2):127-30. doi: 10.1080/13506120500107162.
9
Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.美国黑人迟发性心脏淀粉样变性中的变异序列甲状腺素运载蛋白（异亮氨酸122）
N Engl J Med. 1997 Feb 13;336(7):466-73. doi: 10.1056/NEJM199702133360703.
Zotero 插件